Fluticasone (Flixotide Accuhaler) 100 mcg: Supply issue

Supply issue Active

GlaxoSmithKline has advised that there is a temporary delay in the resupply of the Flixotide (Fluticasone) aerosol inhaler, 100 mcg.

Affected product

Due to continued freight delays, there will be a brief out of stock of Flixotide Accuhaler 100 mcg dose. 

  • Chemical: Flucticasone 
  • Presentation: Powder for inhalation, 100 mcg per dose
  • Brand: Flixotide Accuhaler
  • Pharmacode: 402974
  • Subsidy: $7.50
  • Measure / Qty: per 60 dose OP

Schedule listing for flucticasone(external link)

Early December resupply

The supplier advises us that they expect stock of the inhaler to arrive by early December 2022. Note that it will take time for the stock to clear quality assurance and make its way through the supply chain to pharmacies. 

Who to contact

If you have questions about this supply issue you can contact GSK at mel.customersupport@gsk.com

If you have questions about the funding for this product, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

About Pharmac's role in supply management